Literature DB >> 14692028

Surgical treatment of recurrent endometrial carcinoma.

Elio Campagnutta1, Giorgio Giorda, Giovanni De Piero, Francesco Sopracordevole, M Caterina Visentin, Luca Martella, Carlo Scarabelli.   

Abstract

BACKGROUND: Surgery does not have a definite role in the treatment of patients with recurrent endometrial carcinoma, except for those with central pelvic recurrences. The authors describe their experience with surgery in patients with abdominal endometrial recurrences.
METHODS: Between 1988 and 2000, 75 patients with abdominal and pelvic endometrial recurrences underwent secondary rescue surgery. Patients were classified according to the presence or absence of residual tumor after surgery. Therapy after rescue surgery was undertaken at the discretion of the medical oncologist. The progression-free interval and overall survival were defined as the time from secondary rescue surgery to the specific event and were evaluated by the Kaplan-Meier method and the log-rank test. A Cox proportional hazards regression model was used to compare survival with covariates.
RESULTS: Fifty-six patients (74.7%) underwent optimal debulking. Major surgical complications were observed in 23 patients (30.7%). Only 1 postoperative death was observed, although the mortality rate for surgical complications after the postoperative period was 8%. Patients who underwent optimal debulking had a significantly better cumulative survival rate compared with patients who had residual disease (36% vs. 0% at 60 months; P < 0.05). Residual disease, chemotherapy after rescue surgery, and central pelvis-vagina as the only site of recurrence were associated significantly with survival.
CONCLUSIONS: The authors found that this approach was very challenging in terms of the procedures involved, the incidence of major surgical complications, and the high mortality rate. It was useful in increasing overall survival, provided that patients were free of macroscopic disease. Careful selection of patients is needed to minimize mortality. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Year:  2004        PMID: 14692028     DOI: 10.1002/cncr.11868

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Hematogenous metastases in patients with Stage I or II endometrial carcinoma.

Authors:  Paweł Blecharz; Krzysztof Urbański; Anna Mucha-Małecka; Krzysztof Małecki; Marian Reinfuss; Jerzy Jakubowicz; Piotr Skotnicki
Journal:  Strahlenther Onkol       Date:  2011-11-17       Impact factor: 3.621

Review 2.  Treatment for advanced and recurrent endometrial carcinoma: combined modalities.

Authors:  J Alejandro Rauh-Hain; Marcela G Del Carmen
Journal:  Oncologist       Date:  2010-07-21

3.  Analysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients.

Authors:  Reiko Numazaki; Etsuko Miyagi; Katsuyuki Konnai; Masae Ikeda; Akihito Yamamoto; Ryo Onose; Hisamori Kato; Naoyuki Okamoto; Fumiki Hirahara; Hiroki Nakayama
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

4.  Multivariate survival analysis of the patients with recurrent endometrial cancer.

Authors:  Tetsuji Odagiri; Hidemichi Watari; Masayoshi Hosaka; Takashi Mitamura; Yousuke Konno; Tatsuya Kato; Noriko Kobayashi; Satoko Sudo; Mahito Takeda; Masanori Kaneuchi; Noriaki Sakuragi
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

5.  Vaginal vault recurrences of endometrial cancer in non-irradiated patients - Radiotherapy or surgery.

Authors:  Hordur Alexander Hardarson; Lene Nyhøj Heidemann; René dePont Christensen; Ole Mogensen; Kirsten M Jochumsen
Journal:  Gynecol Oncol Rep       Date:  2015-01-16

6.  Isolated abdominal wall metastasis of endometrial carcinoma.

Authors:  Rita Luz; Rui Leal; Jorge Simões; Matilde Gonçalves; Isabel Matos
Journal:  Case Rep Obstet Gynecol       Date:  2014-09-30

7.  High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina.

Authors:  Sushil Beriwal; Dwight E Heron; Robert Mogus; Robert P Edwards; Joseph L Kelley; Paniti Sukumvanich
Journal:  Radiat Oncol       Date:  2008-02-13       Impact factor: 3.481

8.  The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study.

Authors:  Manabu Adachi; Mika Mizuno; Hiroko Mitsui; Hiroaki Kajiyama; Shiro Suzuki; Ryuichiro Sekiya; Fumi Utsumi; Kiyosumi Shibata; Tetsuo Taniguchi; Koji Kawaguchi; Kohei Yokoi; Fumitaka Kikkawa
Journal:  Nagoya J Med Sci       Date:  2015-08       Impact factor: 1.131

9.  Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective study.

Authors:  Yulan Ren; Boer Shan; Daren Shi; Huaying Wang
Journal:  BMC Cancer       Date:  2014-02-26       Impact factor: 4.430

10.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for managing peritoneal carcinomatosis from endometrial carcinoma: a single-center experience of 6 cases.

Authors:  Ahmed Abu-Zaid; Ayman Zaki Azzam; Osama AlOmar; Hany Salem; Tarek Amin; Ismail A Al-Badawi
Journal:  Ann Saudi Med       Date:  2014 Mar-Apr       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.